This is the lay version of the EULAR recommendations for the management of people with axial spondyloarthritis. The original publication can be downloaded from the EULAR website: www.eular.org. van der Heijde D, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis 2017;76:978–991. doi:10.1136/annrheumdis-2016-210770 Introduction EULAR recommendations give advice to […]
Category: Spondyloarthritis
Even patients with well-controlled disease can have high levels of fear
The FAIR questionnaire could be useful both in routine doctor visits and clinical trials to identify a person’s fear levels about their disease and its treatment INTRODUCTION Rheumatoid arthritis is a chronic (long-term) inflammatory disease that affects a person’s joints, causing pain and disability. It can also affect internal organs. Rheumatoid arthritis is more common […]
Possible new onset or worsening of sacroiliitis or arthritis in people taking vedolizumab for IBD
Possible new onset or worsening of sacroiliitis or arthritis in people taking vedolizumab for IBD Vedolizumab might induce arthritis or sacroiliitis in people with IBD INTRODUCTION Inflammatory bowel disease (often shortened to IBD) is a long-term condition that affects a person’s digestive tract. IBD includes two conditions: ulcerative colitis and Crohn’s disease, which share many […]
Disease activity and inflammation is linked to spinal damage, even in early disease
Disease activity is associated with radiographic spinal progression in early axial spondyloarthritis. INTRODUCTION Ankylosing spondylitis is a chronic inflammatory disease. It mainly involves the spine, but may be associated with other diseases, such as psoriasis (a skin disease), inflammatory bowel disease and uveitis (an inflammation in the eye). These non-joint symptoms are known as extra-articular […]
A step closer to defining ‘flare’ in people with axial spondyloarthritis
Flares may be used as outcomes in trials and studies, but to date there is no agreed consensus on how to define them in people with axial spondyloarthritis. INTRODUCTION Spondyloarthritis is an umbrella term for several conditions that share many of the same features and symptoms, including ankylosing spondylitis, psoriatic arthritis and reactive arthritis. Patients […]
Smoking can reduce the efficacy of medicines for axial spondyloarthritis
Smoking may interfere with how biologic medicines reduce inflammation and joint damage in people with axial spondyloarthritis. INTRODUCTION Spondyloarthritis is an umbrella term for several conditions that share many of the same features and symptoms, including ankylosing spondylitis, psoriatic arthritis and reactive arthritis. Patients can also be classified as having axial or non-axial (peripheral) disease, […]
EULAR recommendations for the use of imaging in spondyloarthritis
Imaging techniques are a key component of the classification of spondyloarthritis, allowing patients to be classi- fied into distinct groups and to receive the appropriate treatment. INTRODUCTION Spondyloarthritis is an umbrella term for several conditions that share many of the same features and symptoms, including ankylosing spondylitis, psoriatic arthritis and reactive arthritis. Patients can also […]
Why anti-TNF treatments don’t work the same for everyone
INTRODUCTION Some people who take treatments called anti-TNF drugs for illnesses like rheumatoid arthritis, psoriasis and spondyloarthritides may get less benefit than other people who take the same treatments, because their immune systems stop the drugs working properly. WHAT DO WE KNOW ALREADY? Anti-TNF drugs are used to reduce inflammation (for example joint swelling). […]
